Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis

The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.

Inclusion Criteria:

• The person who is vaccinated with ChAdOx1 (COVID-19 vaccine)
• The person who agrees with the protocol of the study

Exclusion Criteria:

• Age < 18 years
• Pregnants
• Experience of COVID-19 infection